Effect of Combining Phosphodiesterase III Inhibitors With St Thomas Hospital's Solution Used as Transplantation Preservative Solution in Isolated Rat Hearts

Transplantation Proceedings

Volumn 38, Issue 5, 2006, Pages 1253-1258

  Besirli, K ^a   Burhani, S M ^a   Arslan, C ^a   Suzer, O ^a   Sayin, A G ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMRINONE; CYTOKINE; ENOXIMONE; LACTATE DEHYDROGENASE; MILRINONE; PHOSPHODIESTERASE III INHIBITOR; ST THOMAS HOSPITAL SOLUTION;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EFFLUENT; HEART ARREST; HEART EJECTION FRACTION; HEART FUNCTION; HEART GRAFT; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION TIME; HEART MUSCLE ISCHEMIA; HEART PRESERVATION; HEART TRANSPLANTATION; ISOLATED HEART; LEUKOCYTE AGGREGATION; NONHUMAN; PRIORITY JOURNAL; RAT; SYSTOLE; SYSTOLIC BLOOD PRESSURE;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ANIMALS; BICARBONATES; CALCIUM CHLORIDE; CARDIOPLEGIC SOLUTIONS; DIASTOLE; HEART; HEART FUNCTION TESTS; KINETICS; L-LACTATE DEHYDROGENASE; MAGNESIUM; PHOSPHODIESTERASE INHIBITORS; POTASSIUM CHLORIDE; RATS; RATS, WISTAR; REPERFUSION; SODIUM CHLORIDE; SYSTOLE; TISSUE AND ORGAN HARVESTING;

EID: 33745190920     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.02.062     Document Type: Article

References (23)

1. Suzer O., Koseoglu S., and Han G. No beneficial effects of isocolloidoosmotic synthetic colloid addition to St. Thomas Hospital cardioplegic solution in ischemia-reperfusion injury in isolated perfused rat hearts. Gen Pharmacol 32 (1999) 101
2. Drewnowska K., Clemo H.F., and Baumgarten C.M. Prevention of myocardial intracellular edema induced by St. Thomas' Hospital cardioplegic solution. J Mol Cell Cardiol 23 (1991) 1215
3. Hsu D.T., Weng Z.C., Nicolosi A.C., et al. Quantitative effects of myocardial edema on the left ventricular pressure-volume relation. Influence of cardioplegia osmolarity over two hours of ischemic arrest. J Thorac Cardiovasc Surg 106 (1993) 651
4. Michel P., Vial R., Rodriguez C., et al. A comparative study of the most widely used solutions for cardiac graft preservation during hypothermia. J Heart Lung Transplant 21 (2002) 1030
5. Levy J.H., Bailey J.M., and Deeb G.M. Intravenous milrinone in cardiac surgery. Ann Thorac Surg 73 (2002) 325
6. Silver P.J. Biochemical aspects of inhibition of cardiovascular low (Km) cyclic adenosine monophosphate phosphodiesterase. Am J Cardiol 63 (1989) 2A
7. Walsh M.P., Kargacin G.J., Kendrick-Jones J., et al. Intracellular mechanisms involved in the regulation of vascular smooth muscle tone. Can J Physiol Pharmacol 73 (1995) 565
8. Murray K.J. Cyclic AMP and mechanisms of vasodilation. Pharmacol Ther 47 (1990) 329
9. Rump A., Acar D., and Klaus W. A quantitative comparison of functional and anti-ischaemic effects of the phosphodiesterase-inhibitors, amrinone, milrinone and levosimendan in rabbit isolated hearts. Br J Pharmacol 112 (1994) 757
10. Rechtman M.P., Van derZypp A., and Majewski H. Amrinone reduces ischaemia-reperfusion injury in rat heart. Eur J Pharmacol 402 (2000) 255
11. Suzer O., Bozkurt A.K., Suzer A., et al. Izole kobay kalplerinde iskemik arrest sonrasi levosimendan ve amrinonun inotropik etkilerinin karsilastirilmasi. Gogus Kalp Damar Cerrahisi Dergisi 4 (1996) 4
12. Suzer O., Bozkurt A.K., Suzer A., et al. Levosimendan is a more potent inotropic agent than amrinone after ischemia in isolated perfused guinea pig hearts. Br J Anaesth 76 suppl 1 (1996) A9
13. Honerjager P. Pharmacology of bipyridine phosphodiesterase III inhibitors. Am Heart J 121 part 2 (1991) 1939
14. Katzung B.G., and Parmley W.W. Cardiac glycosides & other drugs used in congestive heart failure. In: Katzung B.G., and Parmley W.W. (Eds). Basic and Clinical Pharmacology. 5th ed. (1996), Lange, East Norwalk, Conn 197
15. Lowes B.D., Higginbotham M., Petrovich L., et al., Enoximonee Study Group. Low-dose enoximone improves exercise capacity in chronic heart failure. J Am Coll Cardiol 36 (2000) 501
16. Mitrovic V., Strasser R., Berwing K., et al. Acute effects of enoximone after intracoronary administration on hemodynamics, myocardial perfusion and regional wall motion. Z Kardiol 85 (1996) 856
17. Koksal C., Suzer O., Bozkurt A.K., et al. Comparison of enoximone, amrinone, or levosimendan enriched St. Thomas' hospital cardioplegic solutions used for myocardial preservation in isolated Guinea pig hearts. Acta Medica (Hradec Kralove) 45 (2002) 93
18. Saltman A.E., Gaudette G.R., Levitsky S., et al. Amrinone preconditioning in the isolated perfused rabbit heart. Ann Thorac Surg 70 (2000) 609
19. Doyle A.R., Dhir A.K., Moors A.H., et al. Treatment of preoperative low cardiac output syndrome. Ann Thorac Surg 59 (1995) S3
20. Mikawa K., Akamatsu H., Nishina K., et al. The effect of phosphodiesterase III inhibitors on human neutrophil function. Crit Care Med 28 (2000) 1001
21. Feathersone R.L., Chambers D.J., and Kelly F.J. Comparison of phosphodiesterase inhibitors of differing isoenzyme selectivity added to St. Thomas Hospital cardioplegic solution used for hypothermic preservation of rat lungs. Am J Respir Crit Care Med 162 (2000) 850
22. Takeuchi K., del Nido P.J., Ibrahim A.E., et al. Vesnarinone and amrinone reduce the systemic inflammatory response syndrome. J Thorac Cardiovasc Surg 117 (1999) 375
23. Chang-Chun C., Matsuda H., Sawa Y., et al. Effect of cyclic adenosine monophosphate phosphodiesterase inhibitor, DN-9693, on myocardial reperfusion injury. Ann Thorac Surg 52 (1991) 495